CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Relapsed Chronic Lymphocytic Leukemia (CLL).

Ohio federal judge dismisses IRA suit brought by US Chamber of Commerce

The federal government has defeated another lawsuit against the Inflation Reduction Act, this time brought by the US Chamber of Commerce. An Ohio federal judge

August 10, 2024

Methadone treatment gets first major update in over 20 years

The federal government is unveiling new regulations meant to modernize methadone treatment, the first major update to patient care standards at methadone clinics in more

February 1, 2024

Mastercard Unveils Virtual Cards to Streamline Healthcare Claim Settlements

What You Should Know: – Mastercard, a global leader in payments, is pioneering a revolutionary solution using its cutting-edge virtual card technology. – This first-of-its-kind

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.